Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
CYTK — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

13.24

Margin Of Safety %

Put/Call OI Ratio

0.37

EPS Next Q Diff

0.08

EPS Last/This Y

0.11

EPS This/Next Y

1.68

Price

76.92

Target Price

104.7

Analyst Recom

1.3

Performance Q

12.72

Upside

-411.2%

Beta

0.41

Ticker: CYTK



21 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-24CYTK65.340.320.49115115
2026-04-27CYTK61.630.3210.06115221
2026-04-28CYTK60.630.382.54121250
2026-04-29CYTK59.570.390.32122714
2026-04-30CYTK63.980.410.65123731
2026-05-01CYTK63.360.410.21125213
2026-05-04CYTK66.010.410.48128528
2026-05-05CYTK76.950.410.68132830
2026-05-06CYTK74.830.440.37145827
2026-05-07CYTK74.280.450.36151357
2026-05-08CYTK76.630.450.04152922
2026-05-11CYTK74.840.460.13149975
2026-05-12CYTK74.770.470.02150520
2026-05-13CYTK77.220.450.59153527
2026-05-14CYTK78.410.450.45153207
2026-05-15CYTK75.850.440.06152119
2026-05-18CYTK75.180.390.0890335
2026-05-19CYTK76.460.390.4390560
2026-05-20CYTK78.720.390.0991334
2026-05-21CYTK78.070.380.0493774
2026-05-22CYTK76.910.370.0795749
DateSymbolLatestP/C OIP/C VolTotal OI
21 items Current Page1 of 1



20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-24CYTK65.29-21.0-66.0-6.58
2026-04-27CYTK61.63-21.0-27.9-6.58
2026-04-28CYTK60.64-21.0-57.3-6.58
2026-04-30CYTK63.98-21.0-120.9-6.58
2026-05-01CYTK63.42-21.0-62.3-6.58
2026-05-04CYTK66.03-21.0-97.7-6.58
2026-05-05CYTK77.12-21.1-188.1-6.58
2026-05-06CYTK74.83-21.1-47.1-6.58
2026-05-07CYTK74.28-20.0-49.9-6.61
2026-05-08CYTK76.87-20.0-81.1-6.61
2026-05-11CYTK74.58-47.6-12.9-6.70
2026-05-12CYTK74.76-49.5-35.5-6.59
2026-05-13CYTK77.21-50.4-57.1-6.59
2026-05-14CYTK78.64-50.4-96.8-6.61
2026-05-15CYTK75.84-50.4-55.5-6.61
2026-05-18CYTK75.16-48.9-75.8-6.55
2026-05-19CYTK76.50-48.9-96.3-6.55
2026-05-20CYTK78.72-48.9-105.4-6.55
2026-05-21CYTK78.03-46.5-75.5-6.55
2026-05-22CYTK76.92-46.5-71.6-6.43
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1



21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-24CYTK-10.29-2.0913.17
2026-04-27CYTK-10.29-1.7912.47
2026-04-28CYTK-7.65-1.7912.47
2026-04-29CYTK-7.82-1.7912.47
2026-04-30CYTK-8.15-1.7912.47
2026-05-01CYTK-8.04-1.7912.47
2026-05-04CYTK-8.39-1.9212.47
2026-05-05CYTK-8.34-1.9212.47
2026-05-06CYTK-9.70-1.9212.47
2026-05-07CYTK-9.70-1.9212.47
2026-05-08CYTK-9.61-1.9212.34
2026-05-11CYTK-9.61-2.3812.34
2026-05-12CYTK-9.66-2.3813.18
2026-05-13CYTK-9.55-2.3813.18
2026-05-14CYTK-9.55-2.3813.18
2026-05-15CYTK-9.71-2.3813.18
2026-05-18CYTK-9.71-1.2213.24
2026-05-19CYTK-8.56-1.2213.24
2026-05-20CYTK-8.53-1.2213.24
2026-05-21CYTK-8.53-1.2213.24
2026-05-22CYTK-8.53-1.2213.24
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS​

-1.67

Avg. EPS Est. Current Quarter

-1.64

Avg. EPS Est. Next Quarter

-1.59

Insider Transactions

-8.53

Institutional Transactions

-1.22

Beta

0.41

Average Sales Estimate Current Quarter

17

Average Sales Estimate Next Quarter

26

Fair Value

Quality Score

8

Growth Score

46

Sentiment Score

82

Actual DrawDown %

30.2

Max Drawdown 5-Year %

-72.4

Target Price

104.7

P/E

Forward P/E

PEG

P/S

90.48

P/B

P/Free Cash Flow

EPS

-6.84

Average EPS Est. Cur. Y​

-6.43

EPS Next Y. (Est.)

-4.75

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-784.02

Relative Volume

0.4

Return on Equity vs Sector %

73.3

Return on Equity vs Industry %

88.9

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.14

EBIT Estimation

-71.6
◆ CYTK Healthcare
$76.94
📉
Swing / Pullback
Buy the dip on strong trends
33 /100
WEAK
Trend
0/20
Pullback
2/25
Volume
11/15
Valuation
8/20
TP/AR
4/10
Options
8/10
RSI
60.6
Range 1M
84%
🚀
Momentum Growth
Ride accelerating trends
N/A
36 /100
WEAK
Momentum
7/25
Growth
15/30
Estimates
3/20
Inst/Vol
3/15
Options
8/10
EPS Yr
2.4%
EPS NY
28.1%
52W%
93.2%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +36.1% upside
Quality
7/30
Valuation
8/30
Growth
11/25
Stability
8/10
LT Trend
1/5
Upside
+36.1%
Quality
8
Click a card to see score breakdown Full Analysis →
Cytokinetics, Incorporated
Sector: Healthcare
Industry: Biotechnology
Employees: 673
Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.
CYTK

Latest News

—
Caricamento notizie per CYTK…
stock quote shares CYTK – Cytokinetics, Incorporated Stock Price stock today
news today CYTK – Cytokinetics, Incorporated stock forecast ,stock prediction 2023 2024 2025
marketwatch CYTK – Cytokinetics, Incorporated yahoo finance google finance
stock history CYTK – Cytokinetics, Incorporated invest stock market
stock prices CYTK premarket after hours
ticker CYTK fair value insiders trading